[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AR012286A1 - Ciclopeptolidos - Google Patents

Ciclopeptolidos

Info

Publication number
AR012286A1
AR012286A1 ARP960105235A ARP960105235A AR012286A1 AR 012286 A1 AR012286 A1 AR 012286A1 AR P960105235 A ARP960105235 A AR P960105235A AR P960105235 A ARP960105235 A AR P960105235A AR 012286 A1 AR012286 A1 AR 012286A1
Authority
AR
Argentina
Prior art keywords
expression
tnf
inhibitors
molecules
cyclopeptolids
Prior art date
Application number
ARP960105235A
Other languages
English (en)
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27267982&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR012286(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9523744.2A external-priority patent/GB9523744D0/en
Priority claimed from GBGB9604406.0A external-priority patent/GB9604406D0/en
Priority claimed from GBGB9613990.2A external-priority patent/GB9613990D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of AR012286A1 publication Critical patent/AR012286A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/145—Fungal isolates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K11/02—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof cyclic, e.g. valinomycins ; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15—Depsipeptides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Communicable Diseases (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)

Abstract

Ciclopeptolidos de formula (I) donde A, B, R1Leu, Leu; C, X e Y son como los definidos, estos compuestos son inhibidores de la expresion de moléculas deadicion e inhibidores de TNF, y son usados para el tratamiento de la inflamacion yo tras enfermedades que involucran elevados niveles de expresionde moléculas de adicion y/o mediados por TNF.
ARP960105235A 1995-11-21 1996-11-18 Ciclopeptolidos AR012286A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9523744.2A GB9523744D0 (en) 1995-11-21 1995-11-21 Organic compounds
GBGB9604406.0A GB9604406D0 (en) 1996-03-01 1996-03-01 Organic compounds
GBGB9613990.2A GB9613990D0 (en) 1996-07-04 1996-07-04 Organic compounds

Publications (1)

Publication Number Publication Date
AR012286A1 true AR012286A1 (es) 2000-10-18

Family

ID=27267982

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960105235A AR012286A1 (es) 1995-11-21 1996-11-18 Ciclopeptolidos

Country Status (27)

Country Link
US (1) US6011136A (es)
EP (1) EP0866801B1 (es)
JP (1) JP3463691B2 (es)
KR (1) KR19990071533A (es)
CN (1) CN1125079C (es)
AR (1) AR012286A1 (es)
AT (1) ATE240972T1 (es)
AU (1) AU712900B2 (es)
BR (1) BR9611619B1 (es)
CA (1) CA2237157C (es)
CO (1) CO4770985A1 (es)
CZ (1) CZ154998A3 (es)
DE (1) DE69628323T2 (es)
ES (1) ES2200079T3 (es)
HU (1) HUP9903810A3 (es)
IL (1) IL124310A0 (es)
MX (1) MX9804048A (es)
MY (1) MY115877A (es)
NO (1) NO982280D0 (es)
NZ (1) NZ322909A (es)
PE (1) PE22998A1 (es)
PL (1) PL186010B1 (es)
RU (1) RU2171260C2 (es)
SK (1) SK65698A3 (es)
TR (1) TR199800897T2 (es)
TW (1) TW450978B (es)
WO (1) WO1997019104A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002034283A2 (en) * 2000-10-27 2002-05-02 Novartis Ag Vegh inhibitors and their use
CN101426520A (zh) * 2004-03-17 2009-05-06 诺华疫苗和诊断公司 通过给予组织因子途径抑制剂（tfpi）治疗社区获得性重症肺炎
MX2020010156A (es) 2018-03-29 2021-03-09 Kezar Life Sciences Inhibidores de la secrecion de proteina cdp.
CN118319952B (zh) * 2024-04-09 2024-09-20 青岛西凯生物技术有限公司 一种修复子宫内膜损伤的干细胞制剂及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3832059A1 (de) * 1988-09-21 1990-03-29 Howaldtswerke Deutsche Werft Tauchtiefengesteuerte ausblasventil-einrichtung
DE3832362A1 (de) * 1988-09-23 1990-03-29 Sandoz Ag Neue cyclopeptolide, verfahren zu ihrer herstellung und ihre verwendung
AT396108B (de) * 1991-08-21 1993-06-25 Biochemie Gmbh Neues verfahren und neue zwischenprodukte zur herstellung von 7-aminocephalosporansaeurederivaten
JPH07109299A (ja) * 1993-10-13 1995-04-25 Shionogi & Co Ltd 抗ｈｉｖ物質ペスタヒビン及びその誘導体
ATE187461T1 (de) * 1994-07-27 1999-12-15 Novartis Erfind Verwalt Gmbh Cyklopeptolide
US20040219569A1 (en) * 1999-07-06 2004-11-04 Fruma Yehiely Gene identification method

Also Published As

Publication number Publication date
TR199800897T2 (xx) 1998-08-21
CO4770985A1 (es) 1999-04-30
RU2171260C2 (ru) 2001-07-27
DE69628323T2 (de) 2004-08-19
TW450978B (en) 2001-08-21
NZ322909A (en) 1999-07-29
CA2237157A1 (en) 1997-05-29
SK65698A3 (en) 1998-11-04
KR19990071533A (ko) 1999-09-27
MX9804048A (es) 1998-09-30
IL124310A0 (en) 1998-12-06
CN1202904A (zh) 1998-12-23
JP3463691B2 (ja) 2003-11-05
CN1125079C (zh) 2003-10-22
ES2200079T3 (es) 2004-03-01
PL326755A1 (en) 1998-10-26
HUP9903810A3 (en) 2001-04-28
EP0866801B1 (en) 2003-05-21
EP0866801A1 (en) 1998-09-30
HUP9903810A2 (hu) 2000-04-28
ATE240972T1 (de) 2003-06-15
AU712900B2 (en) 1999-11-18
CZ154998A3 (cs) 1998-08-12
AU7694696A (en) 1997-06-11
BR9611619A (pt) 1999-03-30
NO982280L (no) 1998-05-19
BR9611619B1 (pt) 2010-08-10
CA2237157C (en) 2009-04-07
PE22998A1 (es) 1998-05-12
MY115877A (en) 2003-09-30
NO982280D0 (no) 1998-05-19
JP2000502992A (ja) 2000-03-14
US6011136A (en) 2000-01-04
PL186010B1 (pl) 2003-09-30
DE69628323D1 (en) 2003-06-26
WO1997019104A1 (en) 1997-05-29

Similar Documents

Publication Publication Date Title
ES2183937T3 (es) Inhibidores de la adhesion celular.
ES2170884T3 (es) Acidos alfa-iminohidroxamicos y carboxilicos n-sustituidos, ciclicos y heterociclicos.
ES2139959T3 (es) Derivados de estilbeno utiles como inhibidores de la ciclooxigenasa-2.
ES2148229T3 (es) Eteres y tioeteres en la posicion 17 de 4-aza-esteroides.
ES2093979T3 (es) Esteres nitricos de derivados del acido 2-(2,6-dihalofenilamino)fenilacetico y su procedimiento de preparacion.
ES2186015T3 (es) Derivados de 2-(purin-9-il)-tetrahidrofuran-3,4-diol.
CY1115916T1 (el) Αντιβιοτικες συνθεσεις για θεραπεια του αυτιου
RU94041950A (ru) Использование соединений ряда 3-аролоксипропиламинов в лечении недержания
ES2115237T3 (es) Fenil heterociclos como inhibidores de la ciclooxigenasa-2.
PA8468401A1 (es) Compuestos para el tratamiento de la isquemia
ECSP055609A (es) "Uso de inhibidores de la IkB-quinasa para el tratamiento del dolor"
BR9502707A (pt) Composto composição farmacêutica e método para o tratamento de uma afecção
ES2168737T3 (es) Inhibidores de la oxido nitrico sintasa.
ES2124612T3 (es) Dihidrodibenzo(b,f)azepinas, substituidas, metodo para su preparacion, su utilizacion en el tratamiento de diversos trastornos del sistema nervioso central y composiciones farmaceuticas que las contienen.
PA8541601A1 (es) Derivados espirociclicos nuevos y su uso como inhibidores de fosfodiesterasa-7.
ES2136037B1 (es) Inhibidores de sulfamida-metaloproteasa
ES2178779T3 (es) Nuevas amidas de acidos de piridil alcanos como agentes citoestaticos e inmunosupresores.
ES2089687T3 (es) 4-fenil-piridonas y 4-fenil-2-alcoxipiridinas sustituidas como inhibidores de la hmg-coa-reductasa.
ES2172937T3 (es) 21-hidroxi-6,19-oxidoprogesterona(21oh-6op) como medicamento para tratar el exceso de glucocorticoides.
AR021843A1 (es) Derivados de propanolamina sustituidos con heterociclos, procedimiento para su preparacion, y su utilizacion.
ES2150705T3 (es) Derivados de ester de nitrito esteroideos utiles como farmacos antiinflamatorios.
ES2178761T3 (es) Utilizacion de 1-hidroxi-2-piridonas para el tratamiento de infe cciones cutaneas.
ES2064119T3 (es) Nuevos derivados de aminobenzosultam como inhibidores de la lipoxigenasa.
ES2190471T3 (es) Procedimiento para producir derivados de guanidina, intermedios de dichos compuestos y su produccion.
DE69918972D1 (de) Verwendung von nmda-antagonisten und/oder natriumkanalantagonisten zur behandlung von entzündlichen erkrankungen

Legal Events

Date Code Title Description
FA Abandonment or withdrawal